Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1869 of 5804
-
New drug elafibranor tested in everyday use for rare liver disease
Disease control Recruiting nowThis study will collect information from participants with Primary Biliary Cholangitis (PBC) as they use the drug elafibranor in real world setting. PBC is a progressive rare liver disease in which tubes in the liver called bile ducts are damaged. The liver damage in PBC may le…
Sponsor: Ipsen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
WHO's ICOPE program tested to keep seniors independent
Prevention Recruiting nowThe World Health Organization (WHO) has designed an integrated care program (ICOPE) aimed at maintaining the functions of elderly people to preserve their autonomy. It includes four steps (Screening, Comprehensive Assessment, Personalized Prevention and Care Plan, Follow-up). The…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Can cooking classes and exercise outperform medically tailored groceries for heart and kidney health?
Disease control CompletedThe investigators are piloting a 3 month community-based lifestyle medicine program that incorporates experiences and education in urban agriculture, nutrition, culinary arts, and physical fitness to test the hypothesis whether this improves clinical and socio-behavioral outcomes…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
7-Day diet or exercise showdown in prostate cancer patients
Knowledge-focused Recruiting nowBackground: Prostate cancer is the second most common cancer and the fifth leading cause of death in men worldwide. Tumour growth is attributed to disproportionately greater protein synthesis rates relative to protein breakdown rates. Tumour protein synthesis is modulated by seve…
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New gel shows promise for diabetic wound healing
Disease control CompletedWith the aging of the population, the incidence of diseases such as diabetes, chronic atherosclerotic occlusion, cerebrovascular disease, and cancer is increasing year by year, and has led to an increasing incidence of chronic wounds such as diabetic foot, ischaemic ulcers, venou…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
No more finger pricks? breath test for blood sugar moves forward
Diagnosis Recruiting nowA pilot study carried out by the company ALPHA-MOS in 2017-19 showed that the analysis of volatile organic compounds contained in exhaled air could reliably predict blood glucose levels. Subsequently, the company BOYDSense, a subsidiary of ALPHA-MOS, produced the Module In a Box …
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Can online therapy help MS patients sleep better and protect their brains?
Symptom relief Recruiting nowThe objective of this RCT is to assess the efficacy of one-on-one telehealth CBT-I (tCBT-I) compared to web-based CBT-I (wCBT-I) and treatment as usual (TAU) to improve sleep outcomes (Aim 1), fatigue and quality of life (Aim 2), and promote neuroprotection (Exploratory Aim 3), a…
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New drug aims to boost blood counts in rare pre-leukemia condition
Disease control Recruiting nowStudy researchers think that a drug called enasidenib may help people with clonal cytopenia of undetermined significance (CCUS) because the drug blocks the mutated IDH2 protein, which may improve blood cell counts. The purpose of this study is to find out whether enasidenib is a …
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Earthworm enzyme trial aims to ease long covid and chronic fatigue
Symptom relief Recruiting nowThis will be a pilot multi-arm clinical trial investigating the feasibility of Lumbrokinase (LK) as an intervention in three clinical cohorts: * Long Covid (LC) * Post-treatment Lyme disease syndrome (PTLDS) * Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Phase: PHASE1, PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New heart procedure may better preserve heart function in AFib patients
Symptom relief Recruiting nowThe goal of this clinical trial is to compare the effect of pulmonary vein isolation on atrial function between pulse-field and cryoablation in patients over the age of 18 with paroxysmal atrial fibrillation. The main question it aims to answer is: • Is catheter ablation energy …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a Cardamom-Bacteria spray soothe your eczema?
Symptom relief Recruiting nowBackground: Atopic dermatitis (AD), also called eczema, is a chronic skin condition. AD can make skin dry and itchy, and sometimes it can lead to serious health problems, such as asthma, food allergies, eye infections, and sleep problems. No cure exists for AD. Researchers know …
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New pill could make IVF easier and more effective
Disease control OngoingThis is a multicentre, open-label, dose-finding, phase 2 study that will recruit approximately 90 female subjects undergoing COH for in vitro fertilization (IVF) or intracytoplasmic single sperm injection (ICSI). Three LY01021 dose groups of 40 mg QD, 30 mg QD, and 20 mg QD will …
Phase: PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a blood clot replace root canal fillings? new study tests regenerative approach
Disease control CompletedStatement of problem: Limitations and drawbacks associated with root canal obturation have the potential to impair periapical healing especially in the absence or delay of a proper coronal seal. Aim of the study: Evaluate the endodontic treatment success in terms of resolution o…
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New eye drops aim to restore natural moisture in dry eyes
Disease control CompletedThe purpose of this study is to evaluate the effect of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) on ocular surface characteristics of subjects with dry eye disease (DED).
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New antibody shot could block HIV – first human safety test underway
Prevention CompletedBackground: HIV (human immunodeficiency virus) is the virus that causes AIDS (acquired immunodeficiency syndrome). Researchers want to find new ways to treat or prevent HIV infection. CAP256J3LS is a new product that uses antibodies. Antibodies are naturally occurring proteins; …
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New balloon treatment aims to clear blocked stents without extra surgery
Disease control OngoingThe purpose of the AGENT IDE study is to assess the safety and effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter in patients with in-stent restenosis (ISR) of a previously treated lesion of up to 36 mm in length (by visual estimate) in a native coronary artery 2.…
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Toothpaste, diet advice, or sealants: which best stops Kids' cavities?
Prevention OngoingA study aims to assess the most effective preventive interventions to address the widespread issue of dental caries, affecting an estimated 2 billion people in permanent teeth and over 500 million children in primary teeth globally. Notably, in Pakistan, over 90% of caries-affect…
Phase: NA • Sponsor: Bahria University • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Gentle manual therapy shows promise for fibromyalgia pain relief
Symptom relief CompletedThis study evaluates whether strain counterstrain therapy affects pain, fatigue, psychological status, and quality of life in women diagnosed with fibromyalgia. Participants are assigned to one of three groups: a control group, a conservative treatment group, or a conservative tr…
Phase: NA • Sponsor: Hasan Kalyoncu University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Can a Peer-Led program break the cycle of social isolation in veterans?
Symptom relief Recruiting nowSocial isolation is a negative social determinant of health that affects 1-in-5 adults in the U.S. and 43% of Veterans. Social isolation is estimated to cost the nation $6.7 billion annually in federal healthcare spending. Yet, social isolation has rarely been the direct focus of…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New pacemaker system aims to improve heart rhythm therapy
Disease control OngoingThe goal of this clinical study is to test the clinical safety and performance of the Amvia pacemakers and the Solia CSP S lead when used for left bundle branch area pacing (LBBAP). The patient population consist of patients with cardiac pacemaker indication or cardiac resynchron…
Phase: NA • Sponsor: Biotronik SE & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC